On day 4, SP7 and TGFB1 were significantly upregulated in Treg-CM treated BMSC, while RUNX2 and COL1α2 expression showed an increase compared to BMSC in OM and Non-CM, albeit insignificant (Fig. 3a). The gene discussed is COL1A2; the disease is ocular melanoma.